France Recombinant Proteins Market Size & Outlook
France recombinant proteins market, 2018-2030 (US$M)
Related Markets
France recombinant proteins market highlights
- The France recombinant proteins market generated a revenue of USD 70.9 million in 2022 and is expected to reach USD 169.3 million by 2030.
- The France market is expected to grow at a CAGR of 11.5% from 2023 to 2030.
- In terms of segment, product was the largest revenue generating product & services in 2022.
- Services is the most lucrative product & services segment registering the fastest growth during the forecast period.
Recombinant proteins market data book summary
| Market revenue in 2022 | USD 70.9 million |
| Market revenue in 2030 | USD 169.3 million |
| Growth rate | 11.5% (CAGR from 2022 to 2030) |
| Largest segment | Product |
| Fastest growing segment | Services |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Services, Product |
| Key market players worldwide | Abcam PLC, Sino Biological, Bio-Techne Corp, Genscript Biotech Corp Class H, Bio-Rad Laboratories Inc, Merck KGaA, Thermo Fisher Scientific Inc, Proteintech Group, Enzo Biochem Inc, Abnova, RayBiotech, STEMCELL Technologies |
Other key industry trends
- In terms of revenue, France accounted for 3.4% of the global recombinant proteins market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, UK recombinant proteins market is projected to lead the regional market in terms of revenue in 2030.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 199.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Recombinant Proteins Market Scope
Recombinant Proteins Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
France recombinant proteins market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to recombinant proteins market will help companies and investors design strategic landscapes.
Product was the largest segment with a revenue share of 68.12% in 2022. Horizon Databook has segmented the France recombinant proteins market based on services, product covering the revenue growth of each sub-segment from 2018 to 2030.
- France Recombinant Proteins Product & Services Outlook (Revenue, USD Million, 2018-2030)
- Services
- Product
- Antibodies
- Immune Checkpoint Proteins
- Virus Antigens
- Recombinant Regulatory Proteins
- Hormones
- Others
- Cytokines & Growth Factors
- Interferons (IFNs)
- Interleukins (ILs)
- Others
- Enzymes
- Kinases
- Metabolic Enzymes
- Others
- France Recombinant Proteins Application Outlook (Revenue, USD Million, 2018-2030)
- Drug Discovery & Development
- Research
- Others
- Therapeutics
- Biologics
- Vaccines
- Cell & Gene Therapies
- Others
- France Recombinant Proteins Host Cells Outlook (Revenue, USD Million, 2018-2030)
- Mammalian Systems
- Insect Cells
- Yeast & Fungi
- Bacterial Cells
- Others
- France Recombinant Proteins End Use Outlook (Revenue, USD Million, 2018-2030)
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Diagnostic Laboratories
- Others
Reasons to subscribe to France recombinant proteins market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of France recombinant proteins market databook
-
Our clientele includes a mix of recombinant proteins market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the France recombinant proteins market , including forecasts for subscribers. This country databook contains high-level insights into France recombinant proteins market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
France recombinant proteins market size, by product & services, 2018-2030 (US$M)
France Recombinant Proteins Market Outlook Share, 2022 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
